Teleflex (TFX)
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$138.36-1.14%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · TFX
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $138 TFX trades at 16× p/e, below its 28× p/e peer median. Our $143 fair value sits above the price. We hold it with medium confidence: the peer anchor overstates how cheap it looks. Analysts target $140–$170. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $156.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $482.95 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $167.39 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $19.19 | — | — | TTM | high |
| graham number | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$140.00 – $170.00 (median $156.50) · 10 analysts · as of 2026-08-25
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Richer than its own typical valuation.
Trailing four: 2025-Q3, 2025-Q4, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $114.44 |
| — |
| — |
| TTM |
| high |
| Peer P/FCF | 12M | $188.68 | 24.6 | 7.66 | TTM | high |
| Peer P/E | 12M | $182.27 | 18.7 | 9.74 | ntm analyst | high |
| Peer P/S | 12M | $175.33 | 2.9 | 59.56 | TTM | high |
| PEG | 12M | $613.29 | 70.1 | 8.75 | TTM | high |
| residual income | 12M | $79.64 | — | — | TTM | high |
| Own P/E history | 12M | $111.59 | 12.8 | 8.75 | TTM | high |
| triangulated | 12M | $257.97 | 28.3 | 9.13 | Triangulated | high |
| Peer P/FCF | 3Y | $194.29 | 24.6 | 7.88 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $211.61 | 18.7 | 11.31 | Analyst | medium |
| Peer P/S | 3Y | $141.65 | 2.9 | 48.12 | Analyst | medium |
| PEG | 3Y | $792.61 | 70.1 | 11.31 | Analyst | medium |
| Own P/E history | 3Y | $144.21 | 12.8 | 11.31 | Analyst | medium |
| Peer P/FCF | 5Y | $198.13 | 24.6 | 8.04 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $183.56 | 18.7 | 9.81 | Analyst | high |
| Peer P/S | 5Y | $122.87 | 2.9 | 41.74 | Analyst | high |
| PEG | 5Y | $687.52 | 70.1 | 9.81 | Analyst | high |
| Own P/E history | 5Y | $125.09 | 12.8 | 9.81 | Analyst | high |